Mission statement · Company scope
“Our mission is to expand access to novel molecular diagnostic testing, most immediately in the transplanted organ rejection testing category.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Democratization (primary) · Innovation
- Leads with
- Access
- Best for
- Mission-driven · Climate & health
- Formula
- [Thing] for everyone
- Tone
- Plain
- Length
- 20 words · reading grade 17.6
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_8a89e5fec4ec4e58
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-26 · sec_sentence · 10-K · accession 0001642380-26-000004
View filing ↗0 to compareCompare